These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

706 related items for PubMed ID: 11735093

  • 1. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
    Kay JP, Alemzadeh R, Langley G, D'Angelo L, Smith P, Holshouser S.
    Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093
    [Abstract] [Full Text] [Related]

  • 2. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
    Brunani A, Caumo A, Graci S, Castagna G, Viberti G, Liuzzi A.
    Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
    [Abstract] [Full Text] [Related]

  • 3. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.
    Glueck CJ, Fontaine RN, Wang P, Subbiah MT, Weber K, Illig E, Streicher P, Sieve-Smith L, Tracy TM, Lang JE, McCullough P.
    Metabolism; 2001 Jul; 50(7):856-61. PubMed ID: 11436194
    [Abstract] [Full Text] [Related]

  • 4. The effects of metformin and diet on plasma testosterone and leptin levels in obese men.
    Ozata M, Oktenli C, Bingol N, Ozdemir IC.
    Obes Res; 2001 Nov; 9(11):662-7. PubMed ID: 11707532
    [Abstract] [Full Text] [Related]

  • 5. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
    Chazova I, Almazov VA, Shlyakhto E.
    Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
    [Abstract] [Full Text] [Related]

  • 6. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [Abstract] [Full Text] [Related]

  • 7. Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?
    Onalan G, Goktolga U, Ceyhan T, Bagis T, Onalan R, Pabuçcu R.
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec 01; 123(2):204-11. PubMed ID: 16316811
    [Abstract] [Full Text] [Related]

  • 8. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.
    Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J.
    N Engl J Med; 1994 Nov 03; 331(18):1188-93. PubMed ID: 7935656
    [Abstract] [Full Text] [Related]

  • 9. Short-term metabolic and cardiovascular effects of metformin in markedly obese adolescents with normal glucose tolerance.
    Burgert TS, Duran EJ, Goldberg-Gell R, Dziura J, Yeckel CW, Katz S, Tamborlane WV, Caprio S.
    Pediatr Diabetes; 2008 Dec 03; 9(6):567-76. PubMed ID: 18761646
    [Abstract] [Full Text] [Related]

  • 10. Short-term effects of metformin in type 2 diabetes.
    Eriksson A, Attvall S, Bonnier M, Eriksson JW, Rosander B, Karlsson FA.
    Diabetes Obes Metab; 2007 Jul 03; 9(4):483-9. PubMed ID: 17587390
    [Abstract] [Full Text] [Related]

  • 11. Use of quality control indices in moderately hypocaloric Mediterranean diet for treatment of obesity.
    De Lorenzo A, Petroni ML, De Luca PP, Andreoli A, Morini P, Iacopino L, Innocente I, Perriello G.
    Diabetes Nutr Metab; 2001 Aug 03; 14(4):181-8. PubMed ID: 11716286
    [Abstract] [Full Text] [Related]

  • 12. Beneficial effect of diazoxide in obese hyperinsulinemic adults.
    Alemzadeh R, Langley G, Upchurch L, Smith P, Slonim AE.
    J Clin Endocrinol Metab; 1998 Jun 03; 83(6):1911-5. PubMed ID: 9626118
    [Abstract] [Full Text] [Related]

  • 13. Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio.
    Mulligan K, Yang Y, Wininger DA, Koletar SL, Parker RA, Alston-Smith BL, Schouten JT, Fielding RA, Basar MT, Grinspoon S.
    AIDS; 2007 Jan 02; 21(1):47-57. PubMed ID: 17148967
    [Abstract] [Full Text] [Related]

  • 14. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.
    Fontbonne A, Diouf I, Baccara-Dinet M, Eschwege E, Charles MA.
    Diabetes Metab; 2009 Nov 02; 35(5):385-91. PubMed ID: 19665415
    [Abstract] [Full Text] [Related]

  • 15. Clinical implications of leptin and its potential humoral regulators in long-term low-calorie diet therapy for obese humans.
    Miyawaki T, Masuzaki H, Ogawa Y, Hosoda K, Nishimura H, Azuma N, Sugawara A, Masuda I, Murata M, Matsuo T, Hayashi T, Inoue G, Yoshimasa Y, Nakao K.
    Eur J Clin Nutr; 2002 Jul 02; 56(7):593-600. PubMed ID: 12080397
    [Abstract] [Full Text] [Related]

  • 16. Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity.
    Miyashita Y, Koide N, Ohtsuka M, Ozaki H, Itoh Y, Oyama T, Uetake T, Ariga K, Shirai K.
    Diabetes Res Clin Pract; 2004 Sep 02; 65(3):235-41. PubMed ID: 15331203
    [Abstract] [Full Text] [Related]

  • 17. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
    Sharma PK, Bhansali A, Sialy R, Malhotra S, Pandhi P.
    Clin Endocrinol (Oxf); 2006 Dec 02; 65(6):722-8. PubMed ID: 17121522
    [Abstract] [Full Text] [Related]

  • 18. Double blind clinical trial of mazindol on weight loss blood glucose, plasma insulin and serum lipids in overweight diabetic patients.
    Slama G, Selmi A, Hautecouverture M, Tchobroutsky G.
    Diabete Metab; 1978 Sep 02; 4(3):193-9. PubMed ID: 361463
    [Abstract] [Full Text] [Related]

  • 19. Metformin in the treatment of obesity in subjects with normal glucose tolerance.
    Tankova T, Dakovska L, Kirilov G, Koev D.
    Rom J Intern Med; 2003 Sep 02; 41(3):269-75. PubMed ID: 15526510
    [Abstract] [Full Text] [Related]

  • 20. Effects of a combination of rhGH and metformin on adiponectin levels in patients with metabolic syndrome.
    Herrmann BL, Saller B, Stratmann M, Berg C, Mann K, Janssen OE.
    Horm Metab Res; 2005 Jan 02; 37(1):49-52. PubMed ID: 15702440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.